This case series from a hospital-based academic in vitro fertilization clinic outlines the
feasibility of oocyte cryopreservation for transgender male adolescents after varying degrees
of exposure to pubertal blockers and/or testosterone. A description of each patient's oocyte
cryopreservation cycle is reviewed, including prior exposure to pubertal blockers and/or
testosterone, anti-Mullerian hormone level, stimulation medications, trigger injections,
number of oocytes retrieved and cryopreserved, and complications. All patients tolerated …